Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | AMGN | CELG | GILD | BIIB |
| Company | Vertex Pharmaceutic | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 419.00 | 309.53 | 108.01 | 65.18 | 220.67 |
| High | 421.18 | 313.86 | 108.59 | 65.22 | 221.96 |
| Low | 416.03 | 306.32 | 107.27 | 64.61 | 218.89 |
| Last | 418.64 | 313.48 | 108.24 | 64.81 | 221.77 |
| Change | -0.18 | +6.17 | +0.11 | -0.11 | +2.05 |
| % Change | -0.04% | +2.01% | +0.10% | -0.17% | +0.93% |
| Volume | 283,482 | 1,202,156 | 191,230,496 | 2,372,143 | 264,540 |
| 20-Day Average Volume | 1,093,574 | 2,819,188 | 16,188,930 | 7,272,002 | 1,332,237 |
| Previous Close | 418.82 | 307.31 | 108.13 | 64.92 | 219.72 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 400.64 | 279.49 | 108.17 | 66.11 | 206.32 |
| 20-Day Raw Stochastic | 80.98% | 85.11% | 63.25% | 11.31% | 95.69% |
| 20-Day Relative Strength | 60.12% | 68.21% | 64.69% | 32.45% | 58.39% |
| Weighted Alpha | +21.45 | +35.97 | +46.30 | -21.22 | -26.24 |
| Today's Opinion | 56% Buy | 56% Buy | 100% Buy | 100% Sell | 56% Sell |
| Previous Opinion | 56% Buy | 56% Buy | 100% Buy | 100% Sell | 56% Sell |
| Last Month's Opinion | 24% Buy | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.72% since 05/02/24 | +12.57% since 05/02/24 | -1.97% since 11/13/19 | -0.79% since 05/02/24 | +3.50% since 05/02/24 |
| Low | 394.03 on 05/07/24 | 297.52 on 05/06/24 | 107.27 on 11/20/19 | 64.33 on 05/03/24 | 213.11 on 05/03/24 |
| High | 425.65 on 05/08/24 | 322.60 on 05/03/24 | 110.53 on 11/14/19 | 66.14 on 05/07/24 | 222.40 on 05/06/24 |
| 1-Month | |||||
| %Chg | +3.60% since 04/09/24 | +15.91% since 04/09/24 | +5.14% since 10/18/19 | -7.33% since 04/09/24 | +7.00% since 04/09/24 |
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 102.40 on 10/21/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 425.65 on 05/08/24 | 322.60 on 05/03/24 | 110.70 on 11/13/19 | 69.76 on 04/10/24 | 222.40 on 05/06/24 |
| 3-Month | |||||
| %Chg | -0.91% since 02/09/24 | +7.65% since 02/09/24 | +13.63% since 08/20/19 | -12.02% since 02/09/24 | -8.30% since 02/09/24 |
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 93.41 on 08/23/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 437.00 on 02/27/24 | 322.60 on 05/03/24 | 110.70 on 11/13/19 | 76.21 on 03/11/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | +13.70% since 11/09/23 | +18.68% since 11/09/23 | +14.14% since 05/20/19 | -13.56% since 11/09/23 | -1.63% since 11/09/23 |
| Low | 341.90 on 11/16/23 | 260.52 on 11/21/23 | 89.08 on 07/23/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 448.40 on 01/30/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 108,247,808 | 164,851,840 | 77,035,920 | 80,830,400 | 31,990,572 |
| Shares Outstanding, K | 258,459 | 536,435 | 711,714 | 1,245,077 | 145,597 |
| Annual Sales | 9,869,200,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | 3,619,600,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 2,517,700,000 | 7,447,000,000 | 4,520,000,000 | 6,686,000,000 | 2,290,500,000 |
| Last Quarter Net Income | 968,800,000 | -113,000,000 | 1,691,000,000 | -4,170,000,000 | 393,400,000 |
| 60-Month Beta | 0.39 | 0.60 | 1.41 | 0.22 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | 4.76 on 05/06/24 | 3.96 on 05/02/24 | 2.99 on 10/31/19 | -1.32 on 04/25/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/06/24 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 27.24 | 16.12 | 10.99 | 16.24 | 14.59 |